Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Natus Medical Inc (NASDAQ:BABY)

Delayed Data
As of Feb 11
 +0.10 / +0.29%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Natus Medical, Inc. provides healthcare products, which are used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company products offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. Natus was founded by Maurizio Liverani, John Robert Camber Porter, William New, Jr., Brian Prinn and William W. Moore on May 26, 1987 and is headquartered in Pleasanton, CA.

Contact Information

Natus Medical, Inc.
6701 Koll Center Parkway
Pleasanton California 94566
P:(925) 223-6700
Investor Relations:



Mutual fund holders52.49%
Other institutional42.58%
Individual stakeholders27.87%

Top Executives

James B. HawkinsPresident, Chief Executive Officer & Director
Jonathan A. KennedyChief Financial Officer & Senior Vice President
D. Christopher ChungVP-Medical, Quality & Regulatory Affairs
Ajay A. BhaveVice President-Global Engineering
Kenneth M. TraversoVice President & General Manager-Newborn Care